Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study. Journal of Translational Medicine
Paola Ulivi1, Laura Capelli1, Martina Valgiusti2, Wainer Zoli1, Emanuela Scarpi3, Elisa Chiadini1, Paola Rosetti2, Sara Bravaccini1, Daniele Calistri1, Luca Saragoni4, Andrea Casadei Gardini2, Angela Ragazzini1, Giovanni Luca Frassineti2, Dino Amadori2 and Alessandro Passardi2 1Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) 2Department of Medical Oncology, IRCCS Istituto Scientifico […]
Human papillomavirus molecular testing in women with low grade cervical lesions: experience from an Italian hospital. Anticancer Res
Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis. Italian Journal of Pediatrics
Stefania Antoniazzi1, Dario Cattaneo1, Valentina Perrone1, Carla Carnovale1, Simonetta Cherubini2, Maria Carmela Mugolino2, Francesco Clementi3, Gianvincenzo Zuccotti4, Emilio Clementi15, and Sonia Radice2 1Unit of Clinical Pharmacolpogy, Department of Clinical Sciences, University Hospital “Luigi Sacco”, Università di Milano 2Unit of Clinical Paediatric, Busto Arsizio Hospital 3CNR Institute of Neuroscience 4Department of Pediatrics University Hospital “Luigi Sacco”, […]
Involvement of Target Gene Polymorphisms in 5-Fluorouracil Toxicity: A Case Report. Pharmacology
SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. Journal of Experimental & Clinical Cancer Research
Elisabetta Falvo1, Lidia Strigari2, Gennaro Citro1, Carolina Giordano3, Genoveva Boboc3, Fabiana Fabretti3, Vicente Bruzzaniti2, Luca Bellesi2, Paola Muti4,5, Giovanni Blandino6 and Paola Pinnarò3 1Laboratory of Pharmacokinetic/Pharmacogenomic, Regina Elena National Cancer Institute 2Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute 3Department of Radiation Oncology, Regina Elena National Cancer Institute 4Department of Oncology […]
Investigation of MTHFR, DPYD, and TSER polymorphisms in 5-FU toxicity: a case report
5-Fluorouracil (5-FU) is a chemotherapic drug belonging to the fluoropyrimidine family, broadly used either alone or in combination with other agents. 5-FU indications include palliative and adjuvant treatment of many cancers, including colorectal, breast, head and neck cancers. 5-FU requires enzymatic conversion to the nucleotide floxouridine monophosphate (FdUMP) in order to exert its cytotoxic activity. […]
HPV in exhaled breath condensate of lung cancer patients. British Journal of Cancer
G E Carpagnano1, A Koutelou1, M I Natalicchio2, D Martinelli3, C Ruggieri1, A Di Taranto1, R Antonetti1, F Carpagnano4 and M P Foschino-Barbaro1 1Institute of Respiratory Disease, Department of Medical and Occupational Sciences, Faculty of Medicine, University of Foggia, Foggia, Italy 2III Laboratory of Analysis, Department of Clinical Pathology, Riuniti Hospital Foggia, Foggia, Italy 3Department […]
Stefania Marzinotto, Francesca Sessa, Alessandra Franzoni,“KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay,” Sequencing, vol. 2011, Article ID 895709, 7 pages, 2011. doi:10.1155/2011/895709
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer
Elisabetta Falvo1, Lidia Strigari2, Gennaro Citro1, Carolina Giordano3, Stefano Arcangeli3, Antonella Soriani2, Daniela D’Alessio2, Paola Muti4, Giovanni Blandino5, Isabella Sperduti4 and Paola Pinnarò3 1Laboratory of Pharmacokinetic/Pharmacogenomic, Regina Elena National Cancer Institute 2Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute 3Department of Radiation Oncology, Regina Elena National Cancer Institute 4Scientiphic Direction, Regina […]
The pyrosequencing experience: testing colorectal cancer patients for KRAS status in the clinical practice
Testing KRAS status in advanced colorectal cancers has gained a practice-changing level of evidence, being predictive of resistance to the point of rendering the use of EGFR-inhibitors useless in patients carrying KRAS mutations. Since there is noagreement on the best testing method, different assays are commonly used in the clinical practice to determinate KRAS status. […]